Fractal dimension and white matter changes in multiple sclerosis

Francisco J Esteban1, Jorge Sepulcre, Nieves Vélez de Mendizábal

  • 1Department of Experimental Biology, Systems Biology and Neurodynamics Unit, Faculty of Experimental and Health Sciences, University of Jaén, Campus Las Lagunillas s/n, 23071, Jaén, Spain. festeban@ujaen.es

Neuroimage
|May 15, 2007
PubMed

Insights

Fractal dimension (FD) analysis reveals decreased white matter complexity in multiple sclerosis (MS) patients, even in normal-appearing white matter (NAWM). This finding suggests FD is a sensitive marker for early diffuse brain damage in MS.

Area of Science:

  • Neuroimaging
  • Neurology
  • Biophysics

Background:

  • Multiple sclerosis (MS) causes visible and non-visible white matter (WM) changes.
  • Normal-appearing white matter (NAWM) also shows abnormalities.
  • Fractal dimension (FD) quantifies morphometric variability in complex structures.

Purpose of the Study:

  • To evaluate FD analysis for measuring WM abnormalities in MS using conventional MRI.
  • To specifically detect changes in NAWM.

Main Methods:

  • Voxel-based morphometry optimized for MS to segment the brain.
  • Calculation of FD for the WM-grey matter interface and skeletonized WM.
  • Focused analysis of NAWM FD on lesion-free sections at the centrum semiovale level.

Main Results:

  • MS patients exhibited significantly reduced whole brain WM FD compared to controls.
  • Decreased FD was observed in both lesioned and NAWM areas.
  • FD detected changes in NAWM, indicating early disease-phase alterations.

Conclusions:

  • FD analysis is effective in identifying brain changes in MS patients, including NAWM.
  • FD may serve as a valuable biomarker for diffuse central nervous system damage in early MS.
  • FD offers a quantitative method to assess subtle WM abnormalities.